Karen Hübscher
Director/Board Member at TECAN GROUP AG
Net worth: 360 229 $ as of 30/03/2024
Karen Hübscher active positions
| Companies | Position | Start | End |
|---|---|---|---|
| TECAN GROUP AG | Director/Board Member | 31/03/2012 | - |
| RUTILA RESOURCES LTD | Director/Board Member | - | - |
| SANDOZ GROUP AG | Director/Board Member | 31/07/2023 | - |
| Dispopharm D&P AG | Director/Board Member | - | - |
| FibulaMedical AG | Chief Executive Officer | 31/12/2011 | - |
| Founder | 31/12/2011 | - | |
| Schweizerische Management Gesellschaft | Director/Board Member | - | - |
| IMD Scholarship Foundation | Director/Board Member | - | - |
Sandoz AG
 Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The private company is based in Basel, Switzerland. | Director/Board Member | - | - |
Career history of Karen Hübscher
Former positions of Karen Hübscher
| Companies | Position | Start | End |
|---|---|---|---|
| Novartis Vaccines & Diagnostics Services AG | Corporate Officer/Principal | 31/12/2005 | 31/12/2010 |
| ░░░░░░░░ ░░ | ░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
Training of Karen Hübscher
| Swiss Federal Institute of Technology | Doctorate Degree |
| International Institute for Management Development | Masters Business Admin |
Statistics
International
| Switzerland | 12 |
| Germany | 2 |
| Australia | 2 |
Operational
| Director/Board Member | 8 |
| Chief Executive Officer | 2 |
| Public Communications Contact | 1 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 3 |
| Non-Energy Minerals | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| NOVARTIS AG | Health Technology |
| TECAN GROUP AG | Health Technology |
| SANDOZ GROUP AG | Health Technology |
| Private companies | 8 |
|---|---|
Sandoz AG
Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The private company is based in Basel, Switzerland. | Health Technology |
Solvias AG
 Solvias AG BiotechnologyHealth Technology Solvias AG engages in contract research, development, and manufacturing. It offers analytical, small molecule, biopharmaceutical, solid state development, catalysis technology, custom synthesis and manufacturing, and biological analysis services. The firm serves the pharmaceutical, biotech, medical devices, cosmetics, agro chemical, chemical, eletronic materials, and life sciences industries. The company was founded in 1999 and is headquartered in Kaiseraugst, Switzerland. | Health Technology |
| IMD Scholarship Foundation | |
| Schweizerische Management Gesellschaft | |
BBI Group Pty Ltd.
 BBI Group Pty Ltd. Other Metals/MineralsNon-Energy Minerals BBI Group Ltd. operates as a resource and energy exploration company. Its projects include include Balla Balla and Eucla West Mineral Sands. The company was founded on October 8, 2009 and is headquartered in Sydney, Australia. | Non-Energy Minerals |
| Dispopharm D&P AG | |
| FibulaMedical AG | |
| Novartis Vaccines & Diagnostics Services AG |
- Stock Market
- Insiders
- Karen Hübscher
- Experience
